Tci Wealth Advisors, Inc. Cassava Sciences Inc Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$27.82 - $44.16 $2,392 - $3,797	86 New	86 $2,000
Q2 2022 Jul 19, 2022	BUY	$17.22 - $38.47 $1,825 - $4,077	106 New	106 $3,000
Q1 2022 Apr 29, 2022	SELL	$32.6 - $53.05 $2,640 - $4,297	-81 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$36.77 - $90.91 $478 - $1,181	13 Added 19.12%	81 $4,000
Q3 2021 Oct 29, 2021	BUY	$41.79 - $135.3 $376 - $1,217	9 Added 15.25%	68 $4,000
Q2 2021 Aug 02, 2021	BUY	$32.15 - $89.72 $707 - $1,973	22 Added 59.46%	59 $5,000
Q1 2021 Apr 29, 2021	BUY	$7.09 - $87.95 $262 - $3,254	37 New	37 $2,000

195

13.7M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $101M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.